Defending Fish Oil, Criticizing Glaxo
Steven Salzberg wrote earlier this week about GlaxoSmithKline
Read more
GlaxoSmithkline’s
Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds
The controversial diabetes drug Avandia does raise the risk of heart attack more than other medications of its kind but
Read more
FDA Bars New Patients From Joining Study of Diabetes Drug Tied to Heart Risks | Pharmaceutical Proce
U.S. federal health officials are barring new patients from enrolling in a safety study of GlaxoSmithKline’s controversial diabetes pill Avandia,
Read more
Medical Flops Of The Decade
When it comes to product safety, it has been a rough decade for pharmaceutical and medical device companies. The drug
Read more